A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
We examined the safety, immunogenicity and efficacy of a prime-boost vaccination regime involving two poxvirus malaria subunit vaccines, FP9-PP and MVA-PP, expressing the same polyprotein consisting of six pre-erythrocytic antigens from Plasmodium falciparum. Following safety assessment of single do...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2011
|